Relaxation for perimenopausal and postmenopausal symptoms

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 7, 2014, Pages

  Saensak, Suprawita ^a   Vutyavanich, Teraporn ^b   Somboonporn, Woraluk ^c   Srisurapanont, Manit ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ALPHA RHYTHM; BREATHING RATE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROACUPUNCTURE; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; META ANALYSIS; MUSCLE RELAXATION; NIGHT SWEAT; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; REVIEW; SLEEP DISORDER; SUPERFICIAL NEEDLE INSERTION; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; CLIMACTERIUM; FEMALE; HOT FLASHES; MIDDLE AGED; NEUROFEEDBACK; POSTMENOPAUSE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING;

ACUPUNCTURE THERAPY; ELECTROACUPUNCTURE; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; NEUROFEEDBACK; PERIMENOPAUSE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RELAXATION THERAPY;

EID: 84922392488     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008582.pub2     Document Type: Review

References (49)

1. Fenlon D, Corner J, Haviland JS. A randomized controlled trial of relaxation training to reduce hot flashes in women with primary breast cancer. Journal of Pain and Symptom Management 2008;35(4):397-405.
2. Freedman R, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. American Journal of Obstetrics and Gynecology 1992;167:436-9.
3. Nedstrand E, Wijma K, Wyon Y, Hammar M. Vasomotor symptoms decrease in women with breast cancer randomised to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climaceric 2005;8:243-50.
4. Wyon Y, Wijma K, Nedstrand E, Hammar M. A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Climacteric 2004;7:153-64.
5. Zaborowska E, Brynhildsen J, Danberg S, Fredriksson M, Lindh-Astrand L, Nedstrand E, et al. Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomised studies. Climacteric 2007 2007;10(1):38-45.
6. Ihn-Sook J. Effect of progressive muscle relaxation using biofeedback on perceived stress, stress response, immune response and climacteric symptoms of middle-aged women. Daehan Ganho Haghoeji 2004;34(2):213-24.
7. Irvin JH, Domar AD, Clark C, Zuttermeister PC, Friedman R. The effects of relaxation response training on menopausal symptoms. Journal of Psychosomatic in Obstetrics and Gynecology 1996;17:202-7.
8. Nedstrand E, Wijma K, Wyon Y, Hammar M. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Maturitas 2005;51:154-62.
9. Bair YA, Gold EB, Greendale GA, Sternfeld B, Adler SR, Azari R, et al. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. American Journal of Public Health 2002;92(11):1832-40.
10. Barton D, Loprinzi C, Wahner-Roedler D. Hot flashes: aetiology and management. Drugs & Aging 2001;18(8):597-606.
11. Benson H, Klipper MZ. The Relaxation Response. New York: HarperCollins Publishers, November 2000.
12. Bruck K, Hinckel P. Thermoregulatory noradrenergic and serotonergic pathways to hypothalamic units. Journal of Physiology 1980;304:193-202.
13. Celentano E, Galasso R, Berrino F. Correlates of age at natural menopause in the cohorts of EPIC-Italy. Tumori 2003;89(6):608-14.
14. Celik H, Ayar A, Tug N, Cikim G, Kilic N, Parmaksiz C. Effects of tibolone on plasma homocysteine levels in postmenopausal women. Fertility and Sterility 2002;78(2):247-50.
15. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstetrics and Gynecology 2000;96:351-8.
16. El-Mas MM, Abdel-Rahman AA. Differential modulation by oestrogen of 2-adrenergic and I1-imidazoline receptor-mediated hypotension in female rats. Journal of Applied Physiology 2004;97:1237-44.
17. Evidence Report/Technology Assessment. Menopause-Related Symptoms. Management of Evidence Report/Technology Assessment Number 120. AHRQ Publication No. 05-E016-2, March 2005.
18. Fauci AS, Braunwald E, Isselbacker KJ. Harrison's Principles of Internal Medicine. 14th Edition. New York: McGraw-Hill, 1997.
19. Freedman RR, Roehrs TA. Lack of sleep disturbance from menopausal hot flashes. Fertility and Sterility 2004;82(1):138-44.
20. Freedman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005;12:258-66.
21. Freeman RR. Physiology of hot flashes. American Journal of Human Biology 2001;13:453-64.
22. Freeman EW, Sammel MD, Lin H, Gracia CR, Pien GW, Nelson DB, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstetrics and Gynecology 2007;110:230-40.
23. Germaine LM, Freedman RR. Behavioral treatment of menopausal hot flashes: evaluation by objective methods. Journal of Consulting and Clinical Psychology 1984;52:1072-9.
24. Gold EB, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. American Journal of Epidemiology 2004;159:1189-99.
25. Goldberg RM, Loprinzi CL, O'Fallon JR, Veeder MH, Miser AW, Mailliard JA, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. Journal of Clinical Oncology 1994;12:155-8.
26. Guthrie JR, Dennerstein L, Taffe JR, Donnelly V. Health care-seeking for menopausal problems. Climacteric 2003 Jun;6(2):112-7.
27. Hickey M, Davis SR, Sturdee DW. Treatment of menopausal symptoms: what shall we do now?. Lancet 2005;366(9483):409-21.
28. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
29. Hjemdahl P, Fagius J, Freyschusss U. Muscle sympathetic activity and norepinephrine release during mental challenge in humans. American Journal of Physiology 1989;257:341-7.
30. Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 1992;14:127-41.
31. Hunter M, Liao KL. Evaluation of a four-session cognitive behavioural intervention for menopausal hot flushes. British Journal of Health Psychology 1996;1:113-25.
32. Kaufert PA, Gilbert P, Tate R. The Manitoba project: a re-examination of the link between menopause and depression. Maturitas 1992;14:143-55.
33. Lee DD, Kimura S, DeQuattro V, Davison G. Relaxation therapy lowers blood pressure in hypertensive with raised plasma norepinephrine and blunts pressor response to anger. Clinical and Experimental Hypertension. Part A, Theoretical Practice 1989;11 Suppl 1:191-8.
34. Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD004143.pub4]
35. Mathews KA, Wing RR, Kuller LH, Meilahn EN, Kelsey SF. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. Journal of Consulting and Clinical Psychology 1990;58:345-51.
36. McKinlay SM, Brambilla DJ, Posner J. The normal menopause transition. Maturitas 1992;14:103-15.
37. McMillan TL, Mark S. Complementary and alternative medicine and physical activity for menopausal symptoms women's health. Journal of the American Medical Women's Association 2004;59:270-7.
38. Mosconi P, Donati S, Colombo C, Mele A, Liberati A, Satolli R, Consensus Conference Working Group. Informing women about hormone replacement therapy: the consensus conference statement. BMC Women's Health 2009;9:14.
39. The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
40. Nedstrand E, Wijma K, Wyon Y, Hamma M. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Maturitas 2005;51:154-62.
41. National Institute of Health. NIH State-of-the-Science Conference Statement on Management of Menopause-Related Symptoms. NIH Consensus and State-of-the-Science Statements March 21-23, 2005:5-13.
42. Ost LG. Applied relaxation: description of a coping technique and review of controlled studies. Behaviour Research and Therapy 1987;25(5):397-409.
43. Payne RA. Relaxation Techniques: A Practical Handbook for the Health Care Professional. Third Edition. China: Elsevier Limited, 2005.
44. The Cochrane Collaboration. Review Manager (RevMan) Version 5.2. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2012.
45. SperoffL, Symons J, Kempfert N, Rowan J. The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol on the frequency and intensity of vasomotor symptoms. Menopause 2000;7(6):383-90.
46. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW), Park City, Utah, July 2001. Menopause 2001;8:402-7.
47. World Health Organization. WHO Scientific Group on Research on the Menopause in the 1990s. WHO Technical Report Series. Geneva, Switzerland: WHO, 1996. WHO Scientific Group on Research on the Menopause in the 1990s. WHO Technical Report Series. Geneva, Switzerland: WHO, 1996.
48. Wijma K, Melin A, Nedstrand E, Hammar M. Treatment of menopausal symptoms with applied relaxation: a pilot study. Journal of Behavior Therapy and Experimental Psychiatry 1997;28:251-64.
49. Williams E, Kalilani L, DiBenedetti B, Zhou X, Granger AL, Fehnel SE, et al. Frequency and severity of vasomotor symptoms among perimenopausal and postmenopausal women in the United States. Climacteric 2008;11(1):32-43.